New study aims to cut unnecessary pacemakers after heart valve procedure

NCT ID NCT04139616

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a pre-set treatment plan for managing heart rhythm issues that can occur after transcatheter aortic valve replacement (TAVR). The goal is to reduce the number of patients who receive a permanent pacemaker while ensuring no one is put at risk of sudden cardiac death. Researchers will follow 2,000 patients to see if the standardized approach works better than current varied practices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pre-specified treatment algorithm for managing conduction disturbances
What this could lead to
If successful, this could establish a standard care pathway that reduces the need for permanent pacemakers after TAVR without increasing the risk of dangerous heart rhythm events.
What could go wrong
This is an observational study testing a management strategy, not a new drug or device. Results depend on how well hospitals follow the algorithm, and individual patient factors may still require pacemakers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IUCPQ

    RECRUITING

    Québec, Quebec, G1V 4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.